My Chemo Diary · Encyclopedia

Making sense of the words of cancer care.

Explore genes and biomarkers, cancer types, medicines, tests and side effects. Connect the information and prepare questions for your next appointment.

Official sources · Source-check dates

139 entries

Genes & biomarkers

BRCA1 and BRCA2 variants

BRCA1 / BRCA2 · DNA repair · PARP

DNA repair genes relevant to some treatments and inherited cancer risk.

Read the entry
Genes & biomarkers

KRAS variants

KRAS · G12C / G12D / G12V

The exact variant, such as G12C, matters more than “KRAS positive” alone.

Read the entry
Genes & biomarkers

NRAS variants

NRAS · RAS pathway

A biomarker may help rule out a treatment as well as select one.

Read the entry
Genes & biomarkers

EGFR variants

EGFR · exon 19 / L858R / exon 20

In lung cancer, the precise EGFR alteration matters.

Read the entry
Genes & biomarkers

ALK fusions and rearrangements

ALK · EML4-ALK

An ALK fusion joins ALK to another gene.

Read the entry
Genes & biomarkers

ROS1 fusions

ROS1 · fusion / rearrangement

A gene fusion relevant to treatment in some lung cancers.

Read the entry
Genes & biomarkers

BRAF variants

BRAF · V600E / V600K

The BRAF variant and cancer type influence the treatment combination.

Read the entry
Genes & biomarkers

HER2 / ERBB2 results

ERBB2 · HER2 · IHC / ISH / mutation

Protein expression, gene amplification and gene variants are different findings.

Read the entry
Genes & biomarkers

PIK3CA variants

PIK3CA · PI3K pathway

Relevant to treatment selection in some hormone receptor-positive breast cancers.

Read the entry
Genes & biomarkers

ESR1 variants

ESR1 · estrogen receptor

ER-positive pathology and an ESR1 variant are different pieces of information.

Read the entry
Genes & biomarkers

RET fusions and variants

RET · fusion / mutation · MEN2

Distinguish RET fusions in lung cancer from RET variants in medullary thyroid cancer.

Read the entry
Genes & biomarkers

MET exon 14 and amplification

MET · exon 14 skipping / amplification

MET exon 14 skipping and MET amplification are distinct findings.

Read the entry
Genes & biomarkers

NTRK1 / NTRK2 / NTRK3 fusions

NTRK1 / NTRK2 / NTRK3 · TRK fusion

An NTRK fusion can guide treatment beyond the organ where a cancer started.

Read the entry
Genes & biomarkers

FGFR2 fusions and rearrangements

FGFR2 · fusion / rearrangement

FGFR2 fusions/rearrangements are targets in some bile duct cancers.

Read the entry
Genes & biomarkers

FGFR3 variants

FGFR3 · urothelial cancer

Relevant to treatment in some advanced urothelial cancers.

Read the entry
Genes & biomarkers

IDH1 variants

IDH1 · IDH1 ≠ IDH2

IDH1 and IDH2 are different treatment targets despite their similar names.

Read the entry
Genes & biomarkers

FLT3 variants

FLT3 · ITD / TKD

An AML target where variant type and treatment setting matter.

Read the entry
Genes & biomarkers

BCR::ABL1 fusion

BCR::ABL1 · Philadelphia chromosome · Ph+

A fusion important for targeted treatment and molecular monitoring in CML and related settings.

Read the entry
Genes & biomarkers

KIT variants

KIT · CD117 · GIST

KIT protein positivity and a KIT gene variant are different findings.

Read the entry
Genes & biomarkers

PDGFRA variants

PDGFRA · exon 18 / D842V

In GIST, the exact variant, such as D842V, matters for drug selection.

Read the entry
Genes & biomarkers

Understanding gene and biomarker results

Somatic / germline · pathogenic / VUS · tissue / blood

Read the alteration, sample and clinical meaning together, beyond the gene name.

Read the entry
Cancer types

Breast cancer

Breast cancer

Stage and hormone-receptor/HER2 results help guide care.

Read the entry
Cancer types

Non-small cell lung cancer

Non-small cell lung cancer

Stage and molecular/PD-L1 results can change treatment options.

Read the entry
Cancer types

Colorectal cancer

Colorectal cancer

Colon and rectal cancers may follow different treatment sequences.

Read the entry
Cancer types

Stomach cancer

Stomach cancer

Stage, pathology and biomarkers help guide treatment.

Read the entry
Cancer types

Liver cancer

Liver cancer

Primary liver cancer differs from cancer that has spread to the liver.

Read the entry
Cancer types

Pancreatic cancer

Pancreatic cancer

Resectability and overall health are central to planning.

Read the entry
Cancer types

Prostate cancer

Prostate cancer

Stage, grade, PSA and effects on daily life matter.

Read the entry
Cancer types

Thyroid cancer

Thyroid cancer

The role of radioactive iodine differs by cancer type.

Read the entry
Cancer types

Ovarian cancer

Ovarian cancer

Epithelial ovarian, fallopian tube and primary peritoneal cancers are considered together.

Read the entry
Cancer types

Cervical cancer

Cervical cancer

Discuss stage and plans concerning pregnancy or fertility.

Read the entry
Cancer types

Kidney cancer

Kidney cancer

An introduction focused on renal cell carcinoma in adults.

Read the entry
Cancer types

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma

Start by identifying the subtype and pace of disease.

Read the entry
Cancer types

Small cell lung cancer

Small cell lung cancer · SCLC

Start by understanding the stage and previous treatment.

Read the entry
Cancer types

Esophageal cancer

Esophageal cancer

Treatment planning includes swallowing and nutrition.

Read the entry
Cancer types

Bladder cancer

Bladder cancer

Intravesical treatment differs from systemic medicines.

Read the entry
Cancer types

Endometrial cancer

Endometrial cancer

Distinguish it from cervical cancer when discussing treatment.

Read the entry
Cancer types

Bile duct cancer

Bile duct cancer

Location, resectability and bile drainage guide care.

Read the entry
Cancer types

Head and neck cancer

Head and neck cancer

Care includes swallowing, speech and oral health.

Read the entry
Cancer types

Melanoma

Melanoma

Tumor thickness, stage and sometimes BRAF results guide treatment.

Read the entry
Cancer types

Acute myeloid leukemia

Acute myeloid leukemia

Subtype and genetic results guide prompt treatment planning.

Read the entry
Cancer types

Multiple myeloma

Multiple myeloma

Assess bones, kidneys, anemia and the need for treatment.

Read the entry
Cancer types

Hodgkin lymphoma

Hodgkin lymphoma

Confirm subtype and stage, distinct from non-Hodgkin lymphoma.

Read the entry
Cancer types

Osteosarcoma

Osteosarcoma

Plan biopsy, surgery and chemotherapy together.

Read the entry
Cancer types

Acute lymphoblastic leukemia

Acute lymphoblastic leukemia

Distinguish B- and T-cell subtypes and genetic results.

Read the entry
Cancer types

Chronic lymphocytic leukemia

Chronic lymphocytic leukemia

First assess whether treatment is needed now.

Read the entry
Cancer types

Chronic myeloid leukemia

Chronic myeloid leukemia

BCR::ABL1 and treatment response guide monitoring.

Read the entry
Cancer medicines

Cisplatin

Cisplatin

A platinum-based cytotoxic chemotherapy.

Read the entry
Cancer medicines

Carboplatin

Carboplatin

A platinum chemotherapy often used in combinations.

Read the entry
Cancer medicines

Paclitaxel

Paclitaxel

A taxane chemotherapy that interferes with cell division.

Read the entry
Cancer medicines

Docetaxel

Docetaxel

A taxane chemotherapy used across several cancers.

Read the entry
Cancer medicines

Doxorubicin

Doxorubicin

An anthracycline cytotoxic chemotherapy.

Read the entry
Cancer medicines

Fluorouracil (5-FU)

Fluorouracil (5-FU)

An antimetabolite used in gastrointestinal and other cancers.

Read the entry
Cancer medicines

Capecitabine

Capecitabine

An oral chemotherapy converted into 5-FU in the body.

Read the entry
Cancer medicines

Oxaliplatin

Oxaliplatin

A platinum chemotherapy that can cause cold sensitivity.

Read the entry
Cancer medicines

Irinotecan

Irinotecan

A chemotherapy with an important risk of severe diarrhea.

Read the entry
Cancer medicines

Gemcitabine

Gemcitabine

A chemotherapy that interferes with DNA building blocks.

Read the entry
Cancer medicines

Pembrolizumab

Pembrolizumab

An immune checkpoint inhibitor targeting PD-1.

Read the entry
Cancer medicines

Nivolumab

Nivolumab

A PD-1 inhibitor that supports anti-cancer immune responses.

Read the entry
Cancer medicines

Trastuzumab

Trastuzumab

An antibody therapy targeting HER2.

Read the entry
Cancer medicines

Osimertinib

Osimertinib

A targeted medicine for lung cancers with certain EGFR mutations.

Read the entry
Cancer medicines

Bevacizumab

Bevacizumab

Blocks VEGF, a signal involved in tumor blood-vessel growth.

Read the entry
Cancer medicines

Tarlatamab

Tarlatamab-dlle · Imdelltra

A bispecific T-cell engager that brings immune cells and cancer cells together.

Read the entry
Cancer medicines

Etoposide

Etoposide

A chemotherapy used in combinations for small cell lung cancer and other cancers.

Read the entry
Cancer medicines

Pemetrexed

Pemetrexed

An antifolate used for selected nonsquamous lung cancers and other settings.

Read the entry
Cancer medicines

Cyclophosphamide

Cyclophosphamide

An alkylating chemotherapy used in breast cancer, lymphomas and other cancers.

Read the entry
Cancer medicines

Methotrexate

Methotrexate

An antifolate with cancer-specific routes and schedules.

Read the entry
Cancer medicines

Rituximab

Rituximab

A CD20-targeting antibody used in selected B-cell lymphomas.

Read the entry
Cancer medicines

Atezolizumab

Atezolizumab

An immune checkpoint inhibitor targeting PD-L1.

Read the entry
Cancer medicines

Durvalumab

Durvalumab

An immunotherapy used in selected lung and biliary tract cancers and other settings.

Read the entry
Cancer medicines

Olaparib

Olaparib

An oral PARP inhibitor used under specific genetic and treatment conditions.

Read the entry
Cancer medicines

Imatinib

Imatinib

An oral targeted therapy for selected leukemias and gastrointestinal stromal tumors.

Read the entry
Cancer medicines

Bortezomib

Bortezomib

A proteasome inhibitor used in multiple myeloma and other settings.

Read the entry
Cancer medicines

Tamoxifen

Tamoxifen

A breast cancer hormone therapy acting on estrogen receptors.

Read the entry
Cancer medicines

Letrozole

Letrozole

An aromatase inhibitor that lowers estrogen production.

Read the entry
Cancer medicines

Anastrozole

Anastrozole

A nonsteroidal aromatase inhibitor used in selected breast cancers.

Read the entry
Cancer medicines

Exemestane

Exemestane

A steroidal aromatase inhibitor that suppresses estrogen production.

Read the entry
Cancer medicines

Fulvestrant

Fulvestrant

An injectable hormone therapy that degrades estrogen receptors.

Read the entry
Cancer medicines

Goserelin

Goserelin

A GnRH agonist that suppresses sex hormone production.

Read the entry
Cancer medicines

Leuprolide (leuprorelin)

Leuprolide (leuprorelin)

A GnRH agonist used to suppress androgens in prostate cancer.

Read the entry
Cancer medicines

Abiraterone

Abiraterone

A prostate cancer therapy that inhibits androgen synthesis.

Read the entry
Cancer medicines

Enzalutamide

Enzalutamide

An oral therapy blocking androgen receptor signaling.

Read the entry
Cancer medicines

Apalutamide

Apalutamide

An androgen receptor inhibitor used in selected prostate cancers.

Read the entry
Cancer medicines

Darolutamide

Darolutamide

A medicine blocking androgen signaling in prostate cancer.

Read the entry
Cancer medicines

Degarelix

Degarelix

A GnRH antagonist lowering testosterone in prostate cancer.

Read the entry
Cancer medicines

Palbociclib

Palbociclib

A CDK4/6-targeted therapy used with endocrine treatment.

Read the entry
Cancer medicines

Ribociclib

Ribociclib

A CDK4/6 inhibitor paired with endocrine therapy in selected early or advanced breast cancers.

Read the entry
Cancer medicines

Abemaciclib

Abemaciclib

A CDK4/6 inhibitor for selected breast cancers, with diarrhea needing particular attention.

Read the entry
Cancer medicines

Pertuzumab

Pertuzumab

An antibody used in combination treatment for HER2-positive breast cancer.

Read the entry
Cancer medicines

Trastuzumab deruxtecan

Trastuzumab deruxtecan

An antibody-drug conjugate delivering cytotoxic treatment through HER2 targeting.

Read the entry
Cancer medicines

Alpelisib

Alpelisib

A targeted therapy for selected PIK3CA-mutated breast cancers.

Read the entry
Cancer medicines

Alectinib

Alectinib

An oral targeted therapy for ALK-positive non-small cell lung cancer.

Read the entry
Cancer medicines

Cetuximab

Cetuximab

An EGFR-targeting antibody for selected colorectal and head and neck cancers.

Read the entry
Cancer medicines

Lenvatinib

Lenvatinib

An oral targeted medicine inhibiting multiple growth and blood-vessel signals.

Read the entry
Cancer medicines

Sunitinib

Sunitinib

A multikinase inhibitor for selected kidney cancers, GIST and pancreatic neuroendocrine tumors.

Read the entry
Cancer medicines

Cytarabine

Cytarabine

An antimetabolite used in acute leukemia combination therapy.

Read the entry
Cancer medicines

Azacitidine

Azacitidine

A hematology medicine affecting DNA methylation.

Read the entry
Cancer medicines

Decitabine

Decitabine

A hypomethylating medicine inhibiting DNA methylation.

Read the entry
Cancer medicines

Venetoclax

Venetoclax

An oral leukemia-targeted medicine inhibiting BCL-2.

Read the entry
Cancer medicines

Gilteritinib

Gilteritinib

A targeted therapy for selected FLT3-mutated AML.

Read the entry
Cancer medicines

Dasatinib

Dasatinib

A targeted therapy for Philadelphia chromosome-positive leukemias.

Read the entry
Cancer medicines

Ibrutinib

Ibrutinib

A BTK inhibitor for selected B-cell blood cancers.

Read the entry
Cancer medicines

Acalabrutinib

Acalabrutinib

A BTK-targeted medicine for CLL/SLL and selected mantle cell lymphomas.

Read the entry
Cancer medicines

Vincristine

Vincristine

A vinca alkaloid used in leukemia and lymphoma combinations.

Read the entry
Cancer medicines

Bendamustine

Bendamustine

A chemotherapy for selected lymphomas and CLL.

Read the entry
Cancer medicines

Brentuximab vedotin

Brentuximab vedotin

A lymphoma ADC delivering a drug through CD30 targeting.

Read the entry
Cancer medicines

Polatuzumab vedotin

Polatuzumab vedotin

A CD79b-targeting antibody-drug conjugate for selected B-cell lymphomas.

Read the entry
Cancer medicines

Blinatumomab

Blinatumomab

A B-cell ALL immunotherapy linking CD19 and CD3.

Read the entry
Cancer medicines

Lenalidomide

Lenalidomide

An immunomodulatory medicine for myeloma and selected blood disorders.

Read the entry
Cancer medicines

Pomalidomide

Pomalidomide

An immunomodulatory medicine for selected previously treated myeloma.

Read the entry
Cancer medicines

Daratumumab

Daratumumab

A CD38-targeting antibody for multiple myeloma.

Read the entry
Cancer medicines

Isatuximab

Isatuximab

A CD38-targeting antibody used in myeloma combinations.

Read the entry
Cancer medicines

Carfilzomib

Carfilzomib

A proteasome inhibitor used in selected relapsed/refractory myeloma.

Read the entry
Cancer medicines

Ixazomib

Ixazomib

An oral proteasome inhibitor for myeloma.

Read the entry
Cancer medicines

Melphalan

Melphalan

An alkylating chemotherapy used in myeloma and selected transplant conditioning.

Read the entry
Tests

NGS testing

Next-generation sequencing

Tests that examine multiple genetic changes to help inform treatment options.

Read the entry
Tests

Complete blood count (CBC)

Complete blood count (CBC)

Measures red cells, white cells and platelets.

Read the entry
Tests

Liver function tests

Liver function tests

Checks liver-related enzymes, bilirubin and other substances.

Read the entry
Tests

Kidney function tests

Kidney function tests

Creatinine and eGFR help assess kidney health.

Read the entry
Tests

Electrolyte tests

Electrolyte tests

Checks sodium, potassium and other electrolyte levels.

Read the entry
Tests

CT scan

CT scan

Uses x-rays to create cross-sectional images.

Read the entry
Tests

MRI scan

MRI scan

Creates images using magnets and radio waves.

Read the entry
Tests

PET-CT scan

PET-CT scan

Combines metabolic activity and anatomical imaging.

Read the entry
Tests

Biopsy and pathology report

Biopsy and pathology report

Examines sampled cells or tissues to characterize disease.

Read the entry
Tests

Tumor marker tests

Tumor marker tests

Tests that can help assess treatment and follow-up.

Read the entry
Tests

Echocardiogram

Echocardiogram

Uses ultrasound to assess heart structure and pumping.

Read the entry
Side effects

Cytokine release syndrome

Cytokine release syndrome · CRS

An immune reaction that can occur after some immunotherapies.

Read the entry
Side effects

Neutropenia and fever

Neutropenia and fever

Fever during cancer treatment needs prompt contact with your team.

Read the entry
Side effects

Anemia

Anemia

Low red cells or hemoglobin can cause fatigue and breathlessness.

Read the entry
Side effects

Low platelets and bleeding

Low platelets and bleeding

Low platelets can make bruising and bleeding easier.

Read the entry
Side effects

Nausea and vomiting

Nausea and vomiting

Preventive medicines and early advice can help control symptoms.

Read the entry
Side effects

Diarrhea

Diarrhea

Diarrhea during treatment needs assessment for dehydration and other causes.

Read the entry
Side effects

Constipation

Constipation

Assess stool hardness, pain and abdominal symptoms, not just frequency.

Read the entry
Side effects

Oral mucositis

Oral mucositis

Mouth pain can affect eating and drinking.

Read the entry
Side effects

Peripheral neuropathy

Peripheral neuropathy

Track numbness, sensation changes and difficulty with everyday tasks.

Read the entry
Side effects

Cancer-related fatigue

Cancer-related fatigue

Fatigue may not be fully relieved by rest.

Read the entry
Side effects

Treatment-related hair loss

Treatment-related hair loss

Hair loss and recovery vary with treatment.

Read the entry
Side effects

Hand-foot syndrome

Hand-foot syndrome

Redness and pain can affect palms and soles.

Read the entry
Side effects

Immune-related adverse events

Immune-related adverse events

Immunotherapy can also trigger inflammation in healthy organs.

Read the entry
Cancer Encyclopedia | My Chemo Diary